LEGN
Legend Biotech Corp
NASDAQ: LEGN · HEALTHCARE · BIOTECHNOLOGY
$22.77
-3.35% today
Updated 2026-04-29
Market cap
$4.21B
P/E ratio
—
P/S ratio
4.09x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $45
Volume
1.9M
Legend Biotech Corp (LEGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $238.69M | $429.05M | $287.71M | $722.09M | $1.12B | $1.33B | $1.85B | $1.67B |
| Cash & equivalents | $2.12M | $210.17M | $83.36M | $456.07M | $688.94M | $786.03M | $1.28B | $286.75M |
| Current assets | $230.90M | $326.96M | $207.10M | $593.94M | $949.85M | $1.10B | $1.50B | $1.28B |
| Total liabilities | $226.53M | $420.40M | $410.58M | $122.27M | $353.52M | $586.65M | $597.24M | $629.61M |
| Current liabilities | $52.12M | $159.19M | $127.76M | $115.57M | $229.20M | $297.79M | $216.42M | $277.64M |
| Long-term debt | — | — | — | — | $120.46M | $260.93M | $281.33M | $301.20M |
| Shareholder equity | $12.17M | $8.65M | $-122.87M | $597.77M | $765.94M | $744.31M | $1.25B | $1.04B |
| Retained earnings | $8.47M | $5.69M | $-127.28M | $-116.53M | $-520.11M | $-966.46M | $-1.48B | $-1.66B |
| Accounts receivable | $228.74M | $108.57M | $35.76M | $82.62M | $58.55M | $44.52M | $157.06M | $124.89M |
| Inventory | $11000.00 | $1.14M | $1.16M | $1.80M | $1.75M | $10.35M | $19.43M | $23.90M |
| Goodwill | — | — | — | $-4.85M | — | — | — | — |